Development of levofloxacin glycosylated mesoporous silica nanoparticles for urinary tract infections

Files

4416_pdf.pdf (2.43 MB)
  (Published version)

Date

2024

Authors

Mukhopadhyay, S.
Narayan, R.
Gadag, S.
Shenoy, P.A.
Garg, S.
Ashwini, T.
Nayak, U.Y.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Journal of Applied Pharmaceutical Science, 2024; 14(12):174-179

Statement of Responsibility

Conference Name

Abstract

Nanoparticle drug delivery for infectious disease has paved the way for effective treatment; mesoporous silica nanoparticles (MSNs) with versatile design options, tunable pore size, high surface area, and adequate pore volume have garnered widespread interest. The current study deals with the synthesis of MSNs loaded with levofloxacin (LVF), followed by glycosylation to enhance the uptake by bacterial cells. The MSNs were prepared by modifying Stober’s process. The amino-modified MSNs were glycosylated using D-Glucuronic acid by EDAC-NHS coupling chemistry. The LVF -loaded glycosylated MSNs (GLY-MSN) were characterized for various parameters and in vitro antimicrobial efficacy study. The surface functionalized MSNs had a particle size of 673.6 ± 60.81nm and were found to be spherical from the SEM images. The drug loading capacity for plain MSNs and GLY-MSN was found to be 10.41% ± 0.81% and 11.43% ± 0.93%, respectively. The LVF release from GLY-MSN was found to be 21.02% ± 3.38% whereas that from plain MSN was 7.50% ± 1.31% at the end of 48 hours. The minimum inhibitory concentration of LVF-GLY-MSN on Escherichia coli was found to be lesser than that for LVF and LVF-MSN. Hence, the synthesized GLY-MSN may be an effective drug delivery system for the treatment of drug-resistant bacterial infections.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

Copyright 2024 The Authors. (https://creativecommons.org/licenses/by/4.0/) Access Condition Notes: This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

License

Grant ID

Call number

Persistent link to this record